Deng Si-Si, Wu Le-Yu, Wang Ya-Chao, Cao Peng-Rong, Xu Lei, Li Qian-Ru, Liu Meng, Zhang Lun, Jiang Yue-Jing, Yang Xiao-Yu, Sun Sheng-Nan, Tan Min-jia, Qian Min, Zang Yi, Feng Linyin, Li Jia
From the National Center for Drug Screening, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 189 Guo Shoujing Road, Shanghai 201203, China.
Department of Neuropharmacology, CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China.
J Biol Chem. 2015 Jan 30;290(5):3149-60. doi: 10.1074/jbc.M114.629873. Epub 2014 Dec 15.
Microtubule affinity-regulating kinase 2 (MARK2)/PAR-1b and protein kinase A (PKA) are both involved in the regulation of microtubule stability and neurite outgrowth, but whether a direct cross-talk exists between them remains unclear. Here, we found the disruption of microtubule and neurite outgrowth induced by MARK2 overexpression was blocked by active PKA. The interaction between PKA and MARK2 was confirmed by coimmunoprecipitation and immunocytochemistry both in vitro and in vivo. PKA was found to inhibit MARK2 kinase activity by phosphorylating a novel site, serine 409. PKA could not reverse the microtubule disruption effect induced by a serine 409 to alanine (Ala) mutant of MARK2 (MARK2 S409A). In contrast, mutation of MARK2 serine 409 to glutamic acid (Glu) (MARK2 S409E) did not affect microtubule stability and neurite outgrowth. We propose that PKA functions as an upstream inhibitor of MARK2 in regulating microtubule stability and neurite outgrowth by directly interacting and phosphorylating MARK2.
微管亲和力调节激酶2(MARK2)/PAR-1b和蛋白激酶A(PKA)均参与微管稳定性和神经突生长的调节,但它们之间是否存在直接的相互作用尚不清楚。在此,我们发现由MARK2过表达诱导的微管和神经突生长的破坏被活性PKA所阻断。通过体外和体内的共免疫沉淀和免疫细胞化学证实了PKA与MARK2之间的相互作用。发现PKA通过磷酸化一个新位点丝氨酸409来抑制MARK2激酶活性。PKA不能逆转由MARK2的丝氨酸409突变为丙氨酸(Ala)的突变体(MARK2 S409A)诱导的微管破坏效应。相反,MARK2的丝氨酸409突变为谷氨酸(Glu)(MARK2 S409E)并不影响微管稳定性和神经突生长。我们提出PKA在通过直接与MARK2相互作用并使其磷酸化来调节微管稳定性和神经突生长中作为MARK2的上游抑制剂发挥作用。